Zobrazeno 1 - 10
of 483
pro vyhledávání: '"ROBERT L. REID"'
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 93:34-41
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 93:60-69
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 93:30-39
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 92:28-37
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 92:32-39
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 92:48-53
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 92:30-37
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 92:46-53
Autor:
Robert L. Reid
Publikováno v:
Civil Engineering Magazine. 92:62-69
Autor:
Céline Gérard, Jean-François Arnal, Maud Jost, Jonathan Douxfils, Françoise Lenfant, Coralie Fontaine, René Houtman, David F. Archer, Robert L. Reid, Rogerio A. Lobo, Ulysse Gaspard, Herjan J.T. Coelingh Bennink, Mitchell D. Creinin, Jean-Michel Foidart
Publikováno v:
Expert review of clinical pharmacology, vol 15, iss 2
Gerard, C, Arnal, J-F, Jost, M, Douxfils, J, Lenfant, F, Fontaine, C, Houtman, R, Archer, D F, Reid, R L, Lobo, R A, Gaspard, U, Coelingh Bennink, H J T, Creinin, M D & Foidart, J-M 2022, ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ', Expert review of clinical pharmacology, vol. 15, no. 2, pp. 121-137 . https://doi.org/10.1080/17512433.2022.2054413
Gerard, C, Arnal, J-F, Jost, M, Douxfils, J, Lenfant, F, Fontaine, C, Houtman, R, Archer, D F, Reid, R L, Lobo, R A, Gaspard, U, Coelingh Bennink, H J T, Creinin, M D & Foidart, J-M 2022, ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ', Expert review of clinical pharmacology, vol. 15, no. 2, pp. 121-137 . https://doi.org/10.1080/17512433.2022.2054413
Introduction: Estrogens used in women’s healthcare have been associated with increased risks of venous thromboembolism (VTE) and breast cancer. Estetrol (E4), an estrogen produced by the human fetal liver, has recently been approved for the first t